Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on P... ( REDWOOD CITY Calif. Sept. 8 /- Ca...)

Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on Pas-Port(R)

Date:9/8/2008

REDWOOD CITY, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that it will hold a teleconference at 11:00 a.m. Eastern Time tomorrow, September 9, to provide a positive update on its PAS-Port(R) Proximal Anastomosis System.

Conference Call Details

To access the live conference call via phone, please dial 866-713-8395 in the United States and Canada or +1-617-597-5309 internationally. The conference ID is 57153283. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through September 16, 2008, and may be accessed by dialing 888-286-8010 from the United States and Canada or +1-617-801-6888 internationally. The replay passcode is 32640672. To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of Cardica's website at http://www.cardica.com. Please connect to the website at least 15 minutes prior to the call to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.

About Cardica, Inc.

Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand
'/>"/>

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008
2. Cardica Names Frederick Bauer Vice President of Operations
3. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
4. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
5. Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008
6. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
7. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
8. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
9. Cardica Announces Exercise of Over-Allotment Option
10. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
11. Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock

Post Your Comments:

(Date:11/27/2009)...wswire/ -- Considered a highly risky and controver...gan transplantation is now a life-saving mainstrea...men who gathered at the Winspear Opera House in Da...l centers around the world to celebrate the 25th a... (BRTI), one of the pioneers of solid organ transp...

(Date:11/27/2009).... 27 Team Garmin-Slipstream, the e...to ethical sporting and developing the next genera... will become Team Garmin-Transitions with the addi...e team. Transitions Optical is the world,s leading...st advanced photochromic technology in the widest ...

(Date:11/27/2009)...es may reduce future disease burden, researchers s...-- Encouraging city dwellers to walk and bicycle i...ic health benefits than increased used of low-emis...he study compared the projected health effects in ... for London, England, and Delhi, India: business-...

(Date:11/27/2009)...e; announced today that Spectrum Health (Grand Rap...se orthopedic templating solution and its TraumaCa... (PRWEB) November 27, 2009 -- Voyant Health&tr...apids, Michigan) has licensed its TraumaCad Enterp...Cad Extend workflow solution, to allow its orthope...

(Date:11/27/2009)...ive anatomy education apps from Modality and Lippi...s learning opportunities for iPhone and iPod touch...ember 27, 2009 -- Modality, Inc. and Lippincott ...s Kluwer Health, today announced the availability ...re. Clemente’s Anatomy, Rohen’s Photog...

Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2 Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3 Health News:More Foot Power, Less Car Pollution Best for Health 2 Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2 Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3 Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2 Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3 Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4 Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5

[0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary [0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor [0] More Foot Power, Less Car Pollution Best for Health [0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend [0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store

... - DRAXIS Health Inc. (TSX: DAX),(NASDAQ: DRAX ) ...hree,months ended March 31, 2008. Revenues and ear...se in the first quarter of 2007 as a result of low...the,first quarter of 2007 of non-recurring items a...

...a-PRNewswire-FirstCall/ --,Shengtai Pharmaceutical...aceutical" or "the Company"), a leading manufactur... grade glucose products in China and glucose,and s...0 a.m. Eastern Time on Friday, May 16, 2008 to dis...

...orporation (NYSE: HLS ) today held its 2008 annua...elect directors and provide an update on the,compa...ng in May 2007., More than 88.5% of the outstandi...ore than 87% of the votes,cast: Jon F. Hanson, Cha...

...o the,Medicare physician fee schedule could severe...rve the rehabilitation needs of seniors and people...le decreasing quality of,care, according to the Am...l Business, Tom DiAngelis, PT, vice president of A...

...c.,s parent,company, Team Finance LLC (the "Compan...ended March 31, 2008., The Company previously ann...ent services business line and substantially compl... the anesthesia,management business are reported a...

...s of heart attack, death, study finds , , ...harsh sound a doctor can hear when passing a steth...ate an increased risk of heart attack and death fr... buildup of fatty deposits in one of the two arter...

DRAXIS Health Reports Results for the First Quarter of 2008 Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008 HealthSouth Board Re-Elected at Annual Shareholder Meeting Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress Team Finance LLC Announces First Quarter 2008 Results Noise in Artery Could Warn of Heart Risk

(Date:11/25/2009)... , COLLEGE PARK, Md., Nov. 25 /PRNewswire-US... developing a shaving cream-like foam that stops s... Most Promising Security Idea category of the Glob...unce today. ,, Selected from more than 100 entr... their invention at the GSC Security Summit confer...

(Date:11/25/2009)... , BASKING RIDGE, N.J., Nov. 25 /PRNewswire/ ...ading the development of antithrombotic aptamers w...zzo, PhD, CEO and President, will be presenting at...nce at the New York Palace Hotel in New York City.... (EST) on Tuesday, December 1 and will include an ...

(Date:11/25/2009)... , NEW YORK, Nov. 25 Rep... report is available in its catalogue: ,, Unit...asts to 2015 ,, http://www.reportlinker.com/p...is-and-Forecasts-to-2015.html ,, United States...015 ,, Summary ,, This report is an essent...

[0] Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam [0] Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 [0] Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015

...titutes of Health Small, Business Innovative Res...HOUSTON, April 22 Agennix, Inc. announced today t...lacebo-controlled Phase 2 study,of oral talactofer...he,first clinical trial of talactoferrin in sepsis...alactoferrin, and promising preclinical data,demon...

...aceuticals, the proprietary products division of P...day announced that its development partner,BioAlli... for a Phase III,study of Loramyc(R) (miconazole L...atment of oropharyngeal candidiasis (OPC)., Top l... endpoint of,noninferiority to Mycelex(R) Troche (...

Other Medicine Technology:Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 2 Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 3 Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 4 Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 5 Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis 2 Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis 3

Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis

The Metalite

Adjustable Mobile Shield

Protective Curtain For Barriers

ECONO GUARD

Medicine Products:

The Metalite Adjustable Mobile Shield Protective Curtain For Barriers ECONO GUARD

Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on P...( REDWOOD CITY Calif. Sept. 8 /- Ca...),Health